Platelet hyperaggregability in patients with atrial fibrillation

Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow

(2014) Natasha M. Rogers et al.   Frontiers in Physiology

Myeloperoxidase induces the priming of platelets

(2013) H. Kolarova et al.   FREE RADICAL BIOLOGY AND MEDICINE

Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1

(2012) Gábor Csányi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

(2012) David R Soto-Pantoja et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1)

(2012) Joachim Strobel et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Ramipril Sensitizes Platelets to Nitric Oxide

(2012) Scott R. Willoughby et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology

(2011) Yoshinori Nishijima et al.   CARDIOVASCULAR RESEARCH

Pathogenic Cycle Between the Endogenous Nitric Oxide Synthase Inhibitor Asymmetrical Dimethylarginine and the Leukocyte-Derived Hemoprotein Myeloperoxidase

(2011) Eike-Christin von Leitner et al.   CIRCULATION

Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease

(2011) E. Schepers et al.   Clinical Journal of the American Society of Nephrology

Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)

(2011) Melinda J. Carrington et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase

(2010) Thomas W Miller et al.   BRITISH JOURNAL OF PHARMACOLOGY

Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation

(2010) Eileen M. Bauer et al.   CARDIOVASCULAR RESEARCH

Recruitment of Immune Cells Across Atrial Endocardium in Human Atrial Fibrillation

(2010) Takeshi Yamashita et al.   CIRCULATION JOURNAL

The impact of rapid atrial pacing on ADMA and endothelial NOS

(2010) Andreas Goette et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

(2010) Volker Rudolph et al.   NATURE MEDICINE

Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease

(2009) Betty S. van der Veen et al.   ANTIOXIDANTS & REDOX SIGNALING

N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study

(2008) M. Ozaydin et al.   EUROPEAN HEART JOURNAL

Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function

(2008) Tanja K. Rudolph et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes

(2008) E. Schepers et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling

(2007) J. S. Isenberg et al.   BLOOD